Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
The American Journal of Surgical Pathology|March 3, 2020
Genetic Basis of Extramedullary Plasmablastic Transformation of Multiple MyelomaYing Liu, Fatima Jelloul, Yanming Zhang, et al.
British Journal of Haematology|June 13, 2009
Phase II study of a TLR-9 agonist (1018 ISS) with rituximab in patients with relapsed or refractory follicular lymphomaJonathan W Friedberg, Jennifer L Kelly, Donna Neuberg, et al.
The Journal of Molecular Diagnostics : JMD|November 21, 2021
Quantitative Off-Target Detection of Epstein-Barr Virus-Derived DNA in Routine Molecular Profiling of Hematopoietic Neoplasms by Panel-Based Hybrid-Capture Next-Generation SequencingKseniya Petrova-Drus, Andrés E Quesada, Anita S Bowman, et al.
Plos One|March 23, 2019
Baseline identification of clonal V(D)J sequences for DNA-based minimal residual disease detection in multiple myelomaEven H Rustad, Malin Hultcrantz, Venkata D Yellapantula, et al.
British Journal of Haematology|December 12, 2018
Allogeneic haematopoietic cell transplantation impacts on outcomes of mantle cell lymphoma with TP53 alterationsRichard J Lin, Caleb Ho, Patrick D Hilden, et al.
The Journal of Molecular Diagnostics : JMD|December 28, 2018
Establishment of Immunoglobulin Heavy (IGH) Chain Clonality Testing by Next-Generation Sequencing for Routine Characterization of B-Cell and Plasma Cell NeoplasmsMaria E Arcila, Wayne Yu, Mustafa Syed, et al.
The Journal of Molecular Diagnostics : JMD|December 16, 2023
Quantification of Measurable Residual Disease Detection by Next-Generation Sequencing-Based Clonality Testing in B-Cell and Plasma Cell NeoplasmsYing Liu, Caleb Ho, Wayne Yu, et al.
Blood Advances|May 16, 2019
Clinicopathologic and genetic characterization of nonacute NPM1-mutated myeloid neoplasmsSanjay S Patel, Caleb Ho, Ryan N Ptashkin, et al.
Haematologica|August 30, 2023
Immunochemotherapy plus lenalidomide for high-risk mantle cell lymphoma with measurable residual disease evaluationZachary D Epstein-Peterson, Esther Drill, Umut Aypar, et al.
The Journal of Molecular Diagnostics : JMD|November 20, 2020
Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing: Feasibility, Challenges, and Direct Comparison with High-Sensitivity Flow CytometryCaleb Ho, Mustafa Syed, Mikhail Roshal, et al.
Pageof 8